Evaluation of the Carcinogenic Potential of Insulin Glargine (LANTUS) in Rats and Mice
Abstract
References
Cite article
Cite article
Cite article
Download to reference manager
If you have citation software installed, you can download article citation data to the citation manager of your choice
Information, rights and permissions
Information
Published In
Keywords
Authors
Metrics and citations
Metrics
Journals metrics
This article was published in International Journal of Toxicology.
VIEW ALL JOURNAL METRICSArticle usage*
Total views and downloads: 749
*Article usage tracking started in December 2016
Articles citing this one
Receive email alerts when this article is cited
Web of Science: 82 view articles Opens in new tab
Crossref: 0
-
Whisker-evoked neurovascular coupling is preserved during hypoglycemia...
-
Management of spontaneous diabetes mellitus in a companion rat (Rattus...
-
Astrocyte regulation of cerebral blood flow during hypoglycemia
-
Evaluation of Cell Proliferation in Rat Mammary Glands Is Not Predicti...
-
Long‐term insulin treatment leads to a change in myosin heavy chain fi...
-
Insulin-like growth factor 1 receptor activation promotes mammary glan...
-
Impact of prebiotics on metabolic and behavioral alterations in a mous...
-
Nonclinical pharmacology and toxicology of the first biosimilar insuli...
-
Regulatory Forum Opinion Piece...
-
Non-metabolisable insulin glargine does not promote breast cancer grow...
-
Insulin Analogs: Assessment of Insulin Mitogenicity and IGF-I Activity
-
Mammary gland tumor promotion by chronic administration of IGF1 and th...
-
Treatment with insulin (analogues) and breast cancer risk in diabetics...
-
Systematic Literature Review of Basal Bolus Insulin Analogue Therapy d...
-
Carcinogenicity of Biopharmaceuticals
-
Insulin Analogs: Assessment of Insulin Mitogenicity and IGF-I Activity
-
Injection-site Malignant Fibrous Histiocytomas in a Pegvisomant Carcin...
-
Effective antidiabetic and antioxidant fractions of Otos...
-
Identification of a Small Molecular Insulin Receptor Agonist With Pote...
-
Treatment with Insulin Analog X10 and IGF-1 Increases Growth of Colon ...
-
Insulin Receptor Phosphorylation by Endogenous Insulin or the Insulin ...
-
Differences in metabolic and mitogenic signalling of insulin glargine ...
-
Energy loss via urine and faeces – a combustive analysis in diabetic r...
-
Glargine safety, diabetes and cancer
-
The metabolic and mitogenic properties of basal insulin analogues
-
Insulin Glargine and Cancer Risk in Patients with Diabetes: A Meta-Ana...
-
Plasma Exposure to Insulin Glargine and Its Metabolites M1 and M2 Afte...
-
Glargine and Cancer: Can We Now Suggest Closure?
-
Insulin Glargine: A Reevaluation of Rodent Carcinogenicity Findings
-
Insulins: Past, Present, and Future
-
Obesity, Type 2 Diabetes and Cancer
-
The IGF system
-
Type 2 diabetes mellitus and risk of malignancy: is there a strategy t...
-
Diabetes, Insulin Resistance, and Cancer: An Update
-
Controversies in the use of insulin analogues
-
Insulin Glargine and NPH Insulin Increase to a Similar Degree Epitheli...
-
Prise en charge thérapeutique du diabète gestationnel
-
Therapeutic management of gestational diabetes
-
Diabetes Mellitus and Increased Risk of Cancer: Focus on Metformin and...
-
Analogues et dosages d’insuline : le cas général et le cas particulier...
-
Insulin Glargine and Cancer Risk: An Opinion Statement of the Endocrin...
-
Insulin—Carcinogen or Mitogen? Preclinical and Clinical Evidence from ...
-
Insulin analogues and cancer risk: cause for concern or ...
-
Type 2 Diabetes and Cancer: What Is the Connection?
-
When “Flawed” Translates into “Flood”: The Unproven Association Betwee...
-
Risk of malignancies in patients with diabetes treated with human insu...
-
Does diabetes therapy influence the risk of cancer?
-
Use of insulin glargine and cancer incidence in Scotland: a study from...
-
Insulin analogs and pregnancy: an update
-
Insulin glargine and cancer: cause and effect unproven
-
Growth effects of insulin and insulin analogues
-
Insulin Glargine: a review 8 years after its introduction
-
Insulin analogues display IGF‐I‐like mitogenic and anti‐apoptotic acti...
-
Insulin analogues: fears, facts and fantasies
-
Proliferation of Colo-357 Pancreatic Carcinoma Cells and Survival of P...
-
Proliferative effects of insulin analogues on mammary epithelial cells
-
Insulin glargine and receptor‐mediated signalling: clinical implicatio...
-
Glargine blood biotransformation: in vitro appraisal with human insuli...
-
Effects of Insulin on Hepatic Inflammation Induced by Ethanol and Burn...
-
Antidiabetic Activity
-
Novel insulin analogues and its mitogenic potential
-
General Toxicity
-
Nonclinical Pharmacology and Safety Studies of Insulin Administered to...
-
Effects of fenofibrate and insulin on the biosynthesis of unsaturated ...
-
A Critical Appraisal of the Role of Insulin Analogues in the Managemen...
-
A review of basal insulins
-
A review of basal insulins
-
Insulin-Glargin
-
Insulin glargine: A systematic review of a long-acting insulin analogu...
-
Evaluation of the Reproductive Toxicity and Embryotoxicity of Insulin ...
Figures and tables
Figures & Media
Tables
View Options
View options
PDF/ePub
View PDF/ePubGet access
Access options
If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:
loading institutional access options
ACT members can access this journal content using society membership credentials.
ACT members can access this journal content using society membership credentials.
Alternatively, view purchase options below:
Purchase 24 hour online access to view and download content.
Access journal content via a DeepDyve subscription or find out more about this option.